Semaglutide GLP-1 is a medication for weight loss that works by mimicking the effects of a natural hormone in the body called glucagon-like peptide-1 (GLP-1)
Erythropoietic protoporphyria (EPP): randomized phase 3 trials European Union trial (9 months, five implants): In EPP patients, afamelanotide increased painfree direct sunlight exposure (10:0015:00) with median 6.0 h per patient versus 0.8 h on placebo
These results indicate that the primary indirect effect of GIP on the liver is at the level of lipid homeostasis
Phase 2 trials showed up to 24% body weight reduction at the highest dose, and Phase 3 data from the TRIUMPH program pushed that number even higher, reaching 28.7% in participants with obesity and knee osteoarthritis
When Constipation Signals a Need to Adjust Your Treatment Severe constipationdefined as no bowel movement for more than 3 days, accompanied by abdominal pain, bloating, or nausearequires immediate contact with your prescriber
It points to two groups of symptoms that deserve closer attention: reproductive issues such as irregular menstrual cycles and temperature-related effects like chills and hot flashes